Veradermics (MANE) Total Liabilities (2024 - 2026)

Veradermics (MANE) has 3 years of Total Liabilities data on file, last reported at $6.7 million in Q1 2026.

• Quarterly Total Liabilities changed N/A year-over-year to $6.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.7 million (changed N/A YoY) and the FY2025 annual result came in at $9.2 million, up 94.07% from the prior year.
• Total Liabilities eased to $6.7 million in Q1 2026, from $9.2 million in the prior quarter.
• In the past five years, Total Liabilities ranged from a high of $9.2 million in Q4 2025 to a low of $4.7 million in Q4 2024.
• A 3-year average of $6.9 million and a median of $6.7 million in 2026 frame the typical range for Total Liabilities.
• The widest YoY moves for Total Liabilities: up 94.07% in 2025, down 94.07% in 2025.
• Tracing MANE's Total Liabilities over 3 years: stood at $4.7 million in 2024, then jumped by 94.07% to $9.2 million in 2025, then declined by 26.65% to $6.7 million in 2026.
• The last three Total Liabilities figures came in at $6.7 million (Q1 2026), $9.2 million (Q4 2025), and $4.7 million (Q4 2024), per Business Quant data.